Revance Therapeutics, Inc.

STATE OF WISCONSIN INVESTMENT BOARD

Report date

9/30/2024

Quarter

2024 Q3

Filed

11/14/2024

Shares

56,767

Value ($000)

295

Weight

0.0%

2019 Q4 - 2024 Q3 (20 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2024 Q3	11/14/2024	295	0.0%	56,767	9/30/2024
2024 Q2	8/14/2024	146	0.0%	56,767	6/30/2024
2024 Q1	5/14/2024	340	0.0%	69,072	3/31/2024
2023 Q4	2/12/2024	944	0.0%	107,418	12/31/2023
2023 Q3	11/14/2023	895	0.0%	78,032	9/30/2023
2023 Q2	8/14/2023	2,358	0.0%	93,178	6/30/2023
2023 Q1	5/15/2023	2,358	0.0%	73,216	3/31/2023
2022 Q4	2/14/2023	1,501	0.0%	81,314	12/31/2022
2022 Q3	11/14/2022	1,932	0.0%	71,543	9/30/2022
2022 Q2	8/15/2022	1,008	0.0%	72,951	6/30/2022
2022 Q1	5/13/2022	1,732	0.0%	88,800	3/31/2022
2021 Q4	2/11/2022	1,449	0.0%	88,800	12/31/2021
2021 Q3	11/12/2021	2,474	0.0%	88,800	9/30/2021
2021 Q2	8/12/2021	2,632	0.0%	88,800	6/30/2021
2021 Q1	5/17/2021	2,482	0.0%	88,800	3/31/2021
2020 Q4	2/3/2021	2,854	0.0%	100,700	12/31/2020
2020 Q3	11/16/2020	2,610	0.0%	103,800	9/30/2020
2020 Q2	8/12/2020	2,288	0.0%	93,700	6/30/2020
2020 Q1	5/6/2020	3,982	0.0%	269,045	3/31/2020
2019 Q4	2/14/2020	4,026	0.0%	248,045	12/31/2019